ENDPOINTS

Blackstone's GRIN inks epilepsy licensing deal with Angelini, closes $140M Series D

Italian drugmaker Angelini Pharma is set to help GRIN Therapeutics take its neurodevelopmental disorder medicine to regions outside North America. Angelini will pay $50 million upfront and up to $520 million in biobucks to GRIN ...

May 27, 2025 - 13:34
 0
Blackstone's GRIN inks epilepsy licensing deal with Angelini, closes $140M Series D
Italian drugmaker Angelini Pharma is set to help GRIN Therapeutics take its neurodevelopmental disorder medicine to regions outside North America. Angelini will pay $50 million upfront and up to $520 million in biobucks to GRIN ...
Read More

Tags:

Previous Article

Nordic studies show the significance of old-growth forests for biodiversity

Next Article

Environmental shifts are shaping mental health. Here’s what five organizations a...

Related Posts

Exclusive: Insurance startup Devoted Health cuts 5% of workers in small layoff

Exclusive: Insurance startup Devoted Health cuts 5% of ...

May 28, 2025  0

FDA rejects Savara’s rare lung disease drug over limited manufacturing data

FDA rejects Savara’s rare lung disease drug over limite...

May 27, 2025  0

#ASCO25: AstraZeneca details Phase 3 data for oral SERD 'switching' regimen

#ASCO25: AstraZeneca details Phase 3 data for oral SERD...

Jun 1, 2025  0